Abreos Biosciences Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Abreos Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010859
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abreos Biosciences Inc (Abreos Biosciences) is a biotechnology company that develops laboratory-based and point-of-care (POC) tests for precision dosing of biologic drugs. The company’s technology platform veritope, allow monitoring of monoclonal antibody drug levels in blood (novel or biosimilar) to enable personalized dosing of patients. Its reagents and assays can be altered accordingly and can be used to detect the biologic drug in lab-based assays, such as lateral flow assay (LFA) or ELISA for POC testing. It also offers custom assays to pharmaceutical companies during drug development, from pre-clinical research to post-market target testing to benefit pharmacokinetic studies, activity validation, and personalized dosing of biologic drugs, including biosimilar. Abreos Biosciences is headquartered in San Diego, California, the US.

Abreos Biosciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Abreos Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Abreos Biosciences Inc, Medical Devices Deals, 2011 to YTD 2017 9
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Abreos Biosciences Raises Investment Round of Funding 11
Abreos Biosciences Raises Funds in Seed Financing Round 12
Partnerships 13
Abreos Biosciences and Institut Paoli-Calmettes Enter into Research Collaboration 13
Licensing Agreements 14
Abreos Biosciences Enter into License Agreement with University of California San 14
Abreos Biosciences Inc – Key Competitors 15
Abreos Biosciences Inc – Key Employees 16
Abreos Biosciences Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Strategy And Business Planning 18
Oct 03, 2016: Abreos Biosciences Announces The Formation Of A French Subsidiary, Abreos France 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Abreos Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Abreos Biosciences Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Abreos Biosciences Inc, Medical Devices Deals, 2011 to YTD 2017 9
Abreos Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Abreos Biosciences Raises Investment Round of Funding 11
Abreos Biosciences Raises Funds in Seed Financing Round 12
Abreos Biosciences and Institut Paoli-Calmettes Enter into Research Collaboration 13
Abreos Biosciences Enter into License Agreement with University of California San 14
Abreos Biosciences Inc, Key Competitors 15
Abreos Biosciences Inc, Key Employees 16

★海外企業調査レポート[Abreos Biosciences Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ShaMaran Petroleum Corp (SNM):石油・ガス:M&Aディール及び事業提携情報
    Summary ShaMaran Petroleum Corp (ShaMaran Petroleum), formerly Bayou Bend Petroleum Ltd is an independent oil and gas exploration and development company. The corporation explores, produces, and develops oil and gas assets. It holds interests and operates Atrush petroleum property located in Kurdist …
  • Linde AG (LIN)-医療機器分野:企業M&A・提携分析
    Summary Linde AG (Linde) is a provider of industrial gases and engineering services. The company specializes in the planning, procurement, construction and operation of gas production and processing plants. Linde offers a wide range of compressed and liquefied gases, and chemicals, and offers facili …
  • Harbour Centre Development Ltd:戦略・SWOT・企業財務分析
    Harbour Centre Development Ltd - Strategy, SWOT and Corporate Finance Report Summary Harbour Centre Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Mitsubishi Gas Chemical Co Inc (4182):企業の財務・戦略的SWOT分析
    Mitsubishi Gas Chemical Co Inc (4182) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Mitsubishi Heavy Industries Ltd (7011):企業の財務・戦略的SWOT分析
    Mitsubishi Heavy Industries Ltd (7011) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As
    Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report Summary Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • University of Texas MD Anderson Cancer Center:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Ander …
  • AJ Lucas Group Ltd (AJL):石油・ガス:M&Aディール及び事業提携情報
    Summary AJ Lucas Group Ltd (Lucas) is an oil and gas drilling services provider. It provides engineering, construction and drilling services. The company offers directional drilling, pipe line construction and civil engineering, project management and other professional engineering services. It hold …
  • Epizyme Inc (EPZM):製薬・医療:M&Aディール及び事業提携情報
    Summary Epizyme, Inc. (Epizyme) is a biopharmaceutical company that develops novel epigenetic therapies for the treatment of cancer and other disorders. The company discovers and develops small molecule inhibitors of a class of enzymes, namely, histone methyl transferases (HMTs) and other chromatin …
  • VION N.V.:企業の戦略・SWOT・財務情報
    VION N.V. - Strategy, SWOT and Corporate Finance Report Summary VION N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Daiichi Sankyo Co Ltd (4568):医療機器:M&Aディール及び事業提携情報
    Summary Daiichi Sankyo Company Ltd (Daiichi Sankyo) is a holding company that carries out the research, development, manufacture, and marketing of pharmaceutical products. The company offers a wide range of prescription drugs, over-the-counter (OTC) drugs, vaccines, and others. Its portfolio encompa …
  • Dufry AG (DUFN):企業の財務・戦略的SWOT分析
    Dufry AG (DUFN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • WSI Industries, Inc.:企業の戦略・SWOT・財務分析
    WSI Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary WSI Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nanjing Pharmaceutical Co Ltd (600713):企業の財務・戦略的SWOT分析
    Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Singapore Press Holdings Limited:企業の戦略・SWOT・財務分析
    Singapore Press Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Singapore Press Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Center for Applied Medical Research:製薬・医療:M&Aディール及び事業提携情報
    Summary Center for Applied Medical Research (CIMA), a subsidiary of University of Navarra, is a medical research center that carries out research in the therapeutic areas of cardiovascular sciences, gene therapy and hepatology, oncology and neurosciences. The center also offers support services such …
  • Sinoma International Engineering Co Ltd:企業の戦略・SWOT・財務情報
    Sinoma International Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sinoma International Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Multi-Color Corp (LABL):企業の財務・戦略的SWOT分析
    Summary Multi-Color Corp (Multi-Color) is a paper and packaging company that develops, manufactures and markets packaging labels. The company offers products such as self adhesive, RFID and NFC, decals and overlays, luminescent, membrane switches, nameplates and signage, foams and gaskets, domed lab …
  • Splash Corporation:戦略・SWOT・企業財務分析
    Splash Corporation - Strategy, SWOT and Corporate Finance Report Summary Splash Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Egypt Gas (EGAS):企業の財務・戦略的SWOT分析
    Summary Egypt Gas (EG) is oil and gas service contractor that offers distribution of natural gas and the implementation of natural gas projects. The company offers services such as mechanical works, supply and construction of pressure reduction and measurement units, suspended and buried gas pipelin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆